Cargando…

Targeting CMV Reactivation to Optimize Care for Critically Ill COVID-19 Patients: A Review on the Therapeutic Potential of Antiviral Treatment

Cytomegalovirus (CMV) reactivation has been linked to adverse clinical outcomes in critically ill patients, with emerging evidence suggesting a potential connection with severe COVID-19. Mechanisms driving this association may include primary lung injury, amplification of systemic inflammation, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schinas, Georgios, Moustaka, Vasiliki, Polyzou, Eleni, Almyroudi, Maria Panagiota, Dimopoulos, George, Akinosoglou, Karolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221621/ https://www.ncbi.nlm.nih.gov/pubmed/37243251 http://dx.doi.org/10.3390/v15051165

Ejemplares similares

The impact of age on intensive care
por: Akinosoglou, Karolina, et al.
Publicado: (2023)

Immune-mediated liver injury following COVID-19 vaccination
por: Schinas, Georgios, et al.
Publicado: (2023)

Preventing Multidrug-Resistant Bacterial Transmission in the Intensive Care Unit with a Comprehensive Approach: A Policymaking Manual
por: Schinas, Georgios, et al.
Publicado: (2023)

Early Fluvoxamine Reduces the Risk for Clinical Deterioration in Symptomatic Outpatients with COVID-19: A Real-World, Retrospective, before–after Analysis
por: Tsiakalos, Aristotelis, et al.
Publicado: (2023)

COVID-19 Pharmacotherapy in Pregnancy: A Literature Review of Current Therapeutic Choices
por: Akinosoglou, Karolina, et al.
Publicado: (2023)

Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/Ritonavir
por: Akinosoglou, Karolina, et al.
Publicado: (2022)

Understanding and Implementing Diagnostic Stewardship: A Guide for Resident Physicians in the Era of Antimicrobial Resistance
por: Schinas, Georgios, et al.
Publicado: (2023)

COVID-19 Vaccination in Patients with Chronic Liver Disease
por: Schinas, Georgios, et al.
Publicado: (2022)

High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review
por: Karaiskos, Ilias, et al.
Publicado: (2023)

Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review
por: Almyroudi, Maria Panagiota, et al.
Publicado: (2022)

Remdesivir Use in the Real-World Setting: An Overview of Available Evidence
por: Akinosoglou, Karolina, et al.
Publicado: (2023)

Epidemiology and Resistance Phenotypes of Carbapenem-Resistant Klebsiella pneumoniae in Corfu General Hospital (2019–2022): A Comprehensive Time Series Analysis of Resistance Gene Dynamics
por: Sorovou, Glykeria, et al.
Publicado: (2023)

Increased Levels of Galectin-3 in Critical COVID-19
por: Nikitopoulou, Ioanna, et al.
Publicado: (2023)

Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients
por: Huntjens, Daan W., et al.
Publicado: (2023)

Antiviral prophylaxis inhibits cytomegalovirus reactivation in critical illness
por: Cowley, NJ, et al.
Publicado: (2015)

Investigating the Role of Anti-TPO Antibodies in HIV-Associated Thrombocytopenia before and after Initiation of HAART: A Case-Control Longitudinal Study
por: Tsiakalos, Aristotelis, et al.
Publicado: (2023)

COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Dimopoulos, George, et al.
Publicado: (2021)

Upraising Stenotrophomonas maltophilia in Critically Ill Patients: A New Enemy?
por: Dimopoulos, George, et al.
Publicado: (2023)

Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation
por: Park, Ga Eun, et al.
Publicado: (2021)

Patterns, Cost, and Immunological Response of MDR vs. Non MDR-Bacteremia: A Prospective Cohort Study
por: Schinas, Georgios, et al.
Publicado: (2023)

Successful Use of Heterologous CMV-Reactive T Lymphocyte to Treat Severe Refractory Cytomegalovirus (CMV) Infection in a Liver Transplanted Patient: Correlation of the Host Antiviral Immune Reconstitution with CMV Viral Load and CMV miRNome
por: Miele, Monica, et al.
Publicado: (2021)

IgA Vasculitis Complicated by Both CMV Reactivation and Tuberculosis
por: Mizerska-Wasiak, Małgorzata, et al.
Publicado: (2021)

Narcissistic rage: The Achilles’ heel of the patient with chronic physical illness
por: Hyphantis, Thomas, et al.
Publicado: (2009)

A Systematic Review and Meta-analysis of Optimized CMV Preemptive Therapy and Antiviral Prophylaxis for CMV Disease Prevention in CMV High-Risk (D+R-) Kidney Transplant Recipients
por: Kumar, Lakshin, et al.
Publicado: (2023)

Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections
por: Pinninti, Swetha, et al.
Publicado: (2023)

604 Risk Factors for Cytomegalovirus (CMV) Reactivation in CMV-seropositive Liver Transplant Patients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

CMV in the gut: a critical review of CMV detection in the immunocompetent host with colitis
por: Goodman, A. L., et al.
Publicado: (2014)

2307. Risk factors for Cytomegalovirus (CMV) reactivation and Association with Clinical Outcomes in Critically Ill Adults with Sepsis: A Pooled Analysis of Prospective Studies
por: Imlay, Hannah, et al.
Publicado: (2019)

CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients
por: Jaskula, Emilia, et al.
Publicado: (2012)

Antiviral agents in the critically ill child
por: Munoz, Flor M.
Publicado: (2000)

The relationship between CMV reactivation, anti-cytokine treatment and mortality in critical COVID-19 patients
por: Gozukucuk, Ramazan, et al.
Publicado: (2023)

Radiologic Features of T10 Paravertebral Muscle Sarcopenia: Prognostic Factors in COVID-19
por: Schinas, Georgios, et al.
Publicado: (2023)

A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Feys, Simon, et al.
Publicado: (2021)

IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients
por: Sadeghi, Mahmoud, et al.
Publicado: (2016)

Donor CMV Reactivation as a Novel Risk Factor for CMV Replication in Seropositive Liver Transplant Recipients
por: Limaye, Ajit P., et al.
Publicado: (2020)

CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality
por: Eberhardt, Kirsten Alexandra, et al.
Publicado: (2023)

Fungal Infections in Critically Ill COVID-19 Patients: Inevitabile Malum
por: Rovina, Nikoletta, et al.
Publicado: (2022)

13. CMV Reactivation in refractory ANCA-associated vasculitis
por: Hassan, Neelam, et al.
Publicado: (2019)

Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection
por: Gordon, Claire L., et al.
Publicado: (2017)

Association of Antiretroviral Therapy with Platelet Function and Systemic Inflammatory Response in People Living with HIV: A Cross-Sectional Study
por: Akinosoglou, Karolina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1b5feoecguhpvdstdbjce2goim